Abstract
Although genome-wide association studies have identified over 100 risk loci that explain ∼33% of familial risk for prostate cancer (PrCa), their functional effects on risk remain largely unknown. Here we use genotype data from 59,089 men of European and African American ancestries combined with cell-type-specific epigenetic data to build a genomic atlas of single-nucleotide polymorphism (SNP) heritability in PrCa. We find significant differences in heritability between variants in prostate-relevant epigenetic marks defined in normal versus tumour tissue as well as between tissue and cell lines. The majority of SNP heritability lies in regions marked by H3k27 acetylation in prostate adenoc7arcinoma cell line (LNCaP) or by DNaseI hypersensitive sites in cancer cell lines. We find a high degree of similarity between European and African American ancestries suggesting a similar genetic architecture from common variation underlying PrCa risk. Our findings showcase the power of integrating functional annotation with genetic data to understand the genetic basis of PrCa.
Original language | English |
---|---|
Article number | 10979 |
Journal | Nature Communications |
Volume | 7 |
DOIs | |
State | Published - 7 Apr 2016 |
Externally published | Yes |
Access to Document
Other files and links
Fingerprint
Dive into the research topics of 'Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Nature Communications, Vol. 7, 10979, 07.04.2016.
Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation
AU - Gusev, Alexander
AU - Shi, Huwenbo
AU - Kichaev, Gleb
AU - Pomerantz, Mark
AU - Li, Fugen
AU - Long, Henry W.
AU - Ingles, Sue A.
AU - Kittles, Rick A.
AU - Strom, Sara S.
AU - Rybicki, Benjamin A.
AU - Nemesure, Barbara
AU - Isaacs, William B.
AU - Zheng, Wei
AU - Pettaway, Curtis A.
AU - Yeboah, Edward D.
AU - Tettey, Yao
AU - Biritwum, Richard B.
AU - Adjei, Andrew A.
AU - Tay, Evelyn
AU - Truelove, Ann
AU - Niwa, Shelley
AU - Chokkalingam, Anand P.
AU - John, Esther M.
AU - Murphy, Adam B.
AU - Signorello, Lisa B.
AU - Carpten, John
AU - Leske, M. Cristina
AU - Wu, Suh Yuh
AU - Hennis, Anslem J.M.
AU - Neslund-Dudas, Christine
AU - Hsing, Ann W.
AU - Chu, Lisa
AU - Goodman, Phyllis J.
AU - Klein, Eric A.
AU - Witte, John S.
AU - Casey, Graham
AU - Kaggwa, Sam
AU - Cook, Michael B.
AU - Stram, Daniel O.
AU - Blot, William J.
AU - Eeles, Rosalind A.
AU - Easton, Douglas
AU - Kote-Jarai, Zsofia
AU - Al Olama, Ali Amin
AU - Benlloch, Sara
AU - Muir, Kenneth
AU - Giles, Graham G.
AU - Southey, Melissa C.
AU - Fitzgerald, Liesel M.
AU - Gronberg, Henrik
AU - Wiklund, Fredrik
AU - Aly, Markus
AU - Henderson, Brian E.
AU - Schleutker, Johanna
AU - Wahlfors, Tiina
AU - Tammela, Teuvo L.J.
AU - Nordestgaard, Børge G.
AU - Key, Tim J.
AU - Travis, Ruth C.
AU - Neal, David E.
AU - Donovan, Jenny L.
AU - Hamdy, Freddie C.
AU - Pharoah, Paul
AU - Pashayan, Nora
AU - Khaw, Kay Tee
AU - Stanford, Janet L.
AU - Thibodeau, Stephen N.
AU - McDonnell, Shannon K.
AU - Schaid, Daniel J.
AU - Maier, Christiane
AU - Vogel, Walther
AU - Luedeke, Manuel
AU - Herkommer, Kathleen
AU - Kibel, Adam S.
AU - Cybulski, Cezary
AU - Wokolorczyk, Dominika
AU - Kluzniak, Wojciech
AU - Cannon-Albright, Lisa
AU - Teerlink, Craig
AU - Brenner, Hermann
AU - Dieffenbach, Aida K.
AU - Arndt, Volker
AU - Park, Jong Y.
AU - Sellers, Thomas A.
AU - Lin, Hui Yi
AU - Slavov, Chavdar
AU - Kaneva, Radka
AU - Mitev, Vanio
AU - Batra, Jyotsna
AU - Spurdle, Amanda
AU - Clements, Judith A.
AU - Teixeira, Manuel R.
AU - Pandha, Hardev
AU - Michael, Agnieszka
AU - Paulo, Paula
AU - Maia, Sofia
AU - Kierzek, Andrzej
AU - Conti, David V.
AU - Albanes, Demetrius
AU - Berg, Christine
AU - Berndt, Sonja I.
AU - Campa, Daniele
AU - Crawford, E. David
AU - Diver, W. Ryan
AU - Gapstur, Susan M.
AU - Gaziano, J. Michael
AU - Giovannucci, Edward
AU - Hoover, Robert
AU - Hunter, David J.
AU - Johansson, Mattias
AU - Kraft, Peter
AU - Le Marchand, Loic
AU - Lindström, Sara
AU - Navarro, Carmen
AU - Overvad, Kim
AU - Riboli, Elio
AU - Siddiq, Afshan
AU - Stevens, Victoria L.
AU - Trichopoulos, Dimitrios
AU - Vineis, Paolo
AU - Yeager, Meredith
AU - Trynka, Gosia
AU - Raychaudhuri, Soumya
AU - Schumacher, Frederick R.
AU - Price, Alkes L.
AU - Freedman, Matthew L.
AU - Haiman, Christopher A.
AU - Pasaniuc, Bogdan
N1 - Funding Information: This work was supported by NIH fellowship F32 GM106584 (AG), NIH grants R01 MH101244(A.G.), R01 CA188392 (B.P.), U01 CA194393(B.P.), R01 GM107427 (M.L.F.), R01 CA193910 (M.L.F./M.P.) and Prostate Cancer Foundation Challenge Award (M.L.F./M.P.). This study makes use of data generated by the Wellcome Trust Case Control Consortium and the Wellcome Trust Sanger Institute. A full list of the investigators who contributed to the generation of the Wellcome Trust Case Control Consortium data is available on www.wtccc.org.uk. Funding for theWellcome Trust Case Control Consortium project was provided by the Wellcome Trust under award 076113. This study makes use of data generated by the UK10K Consortium. A full list of the investigators who contributed to the generation of the data is available online (http://www.UK10K.org). The PRACTICAL consortium was supported by the following grants: European Commission's Seventh Framework Programme grant agreement n 223175 (HEALTH-F2-2009-223175), Cancer Research UK Grants C5047/A7357, C1287/A10118, C5047/A3354, C5047/A10692, C16913/A6135 and The National Institute of Health (NIH) Cancer Post-Cancer GWAS initiative Grant: no. 1 U19 CA 148537-01 (the GAME-ON initiative); Cancer Research UK (C1287/A10118, C1287/A 10710, C12292/A11174, C1281/A12014, C5047/A8384, C5047/A15007 and C5047/A10692), the National Institutes of Health (CA128978) and Post-Cancer GWAS initiative (1U19 CA148537, 1U19 CA148065 and 1U19 CA148112-the GAME-ON initiative), the Department of Defense (W81XWH-10-1-0341), A Linneus Centre (Contract ID 70867902), Swedish Research Council (grant no K2010-70X-20430-04-3), the Swedish Cancer Foundation (grant no 09-0677), grants RO1CA056678, RO1CA082664 and RO1CA092579 from the US National Cancer Institute, National Institutes of Health; US National Cancer Institute (R01CA72818); support from The National Health and Medical Research Council, Australia (126402, 209057, 251533, 396414, 450104, 504700, 504702, 504715, 623204, 940394 and 614296); NIH grants CA63464, CA54281 and CA098758; US National Cancer Institute (R01CA128813, PI: J.Y. Park); Bulgarian National Science Fund, Ministry of Education and Science (contract DOO-119/2009; DUNK01/2-2009; DFNI-B01/28/2012); Cancer Research UK grants [C8197/A10123] and [C8197/A10865]; grant code G0500966/75466; NIHR Health Technology Assessment Programme (projects 96/20/06 and 96/20/99); Cancer Research UK grant number C522/A8649, Medical Research Council of England grant number G0500966, ID 75466 and The NCRI, UK; The US Dept of Defense award W81XWH-04-1-0280; Australia Project Grant [390130, 1009458] and Enabling Grant [614296 to APCB]; the Prostate Cancer Foundation of Australia (Project Grant [PG7] and Research infrastructure grant [to APCB]); NIH grant R01 CA092447; Vanderbilt-Ingram Cancer Center (P30 CA68485); Cancer Research UK [C490/A10124] and supported by the UK National Institute for Health Research Biomedical Research Centre at the University of Cambridge; Competitive Research Funding of the Tampere University Hospital (9N069 and X51003); Award Number P30CA042014 from the National Cancer Institute.
PY - 2016/4/7
Y1 - 2016/4/7
N2 - Although genome-wide association studies have identified over 100 risk loci that explain ∼33% of familial risk for prostate cancer (PrCa), their functional effects on risk remain largely unknown. Here we use genotype data from 59,089 men of European and African American ancestries combined with cell-type-specific epigenetic data to build a genomic atlas of single-nucleotide polymorphism (SNP) heritability in PrCa. We find significant differences in heritability between variants in prostate-relevant epigenetic marks defined in normal versus tumour tissue as well as between tissue and cell lines. The majority of SNP heritability lies in regions marked by H3k27 acetylation in prostate adenoc7arcinoma cell line (LNCaP) or by DNaseI hypersensitive sites in cancer cell lines. We find a high degree of similarity between European and African American ancestries suggesting a similar genetic architecture from common variation underlying PrCa risk. Our findings showcase the power of integrating functional annotation with genetic data to understand the genetic basis of PrCa.
AB - Although genome-wide association studies have identified over 100 risk loci that explain ∼33% of familial risk for prostate cancer (PrCa), their functional effects on risk remain largely unknown. Here we use genotype data from 59,089 men of European and African American ancestries combined with cell-type-specific epigenetic data to build a genomic atlas of single-nucleotide polymorphism (SNP) heritability in PrCa. We find significant differences in heritability between variants in prostate-relevant epigenetic marks defined in normal versus tumour tissue as well as between tissue and cell lines. The majority of SNP heritability lies in regions marked by H3k27 acetylation in prostate adenoc7arcinoma cell line (LNCaP) or by DNaseI hypersensitive sites in cancer cell lines. We find a high degree of similarity between European and African American ancestries suggesting a similar genetic architecture from common variation underlying PrCa risk. Our findings showcase the power of integrating functional annotation with genetic data to understand the genetic basis of PrCa.
UR - http://www.scopus.com/inward/record.url?scp=84963635486&partnerID=8YFLogxK
U2 - 10.1038/ncomms10979
DO - 10.1038/ncomms10979
M3 - Article
C2 - 27052111
AN - SCOPUS:84963635486
SN - 2041-1723
VL - 7
JO - Nature Communications
JF - Nature Communications
M1 - 10979
ER -